StockData
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. (ARMP) stock

ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$3.03+0.05 (+1.68%)

Close on Nov 20, 2026Market cap $112.66MP/E –Yield –

Armata Pharmaceuticals gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Armata Pharmaceuticals

Armata Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Armata Pharmaceuticals figures

See a number that looks wrong?